{
  "slug": "medtronic-illumisite",
  "name": "medtronic-illumisite",
  "description": "The ILLUMISITE™ platform is Medtronic's leading electromagnetic lung navigation system designed to correct for CT-to-body divergence with real-time visualization during lung biopsy procedures. It enhances image clarity, adjusts to dynamic lung environments, and is compatible with digital fluoroscopes, providing continuous guidance for accurate nodule navigation and sampling.",
  "url": "https://optimly.ai/brand/medtronic-illumisite",
  "websiteUrl": "https://medtronicsolutions.com/",
  "logoUrl": "https://logo.clearbit.com/medtronicsolutions.com",
  "baiScore": 41,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Medical Devices",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-10T05:56:43.808Z",
  "verifiedVitals": {
    "website": "https://medtronicsolutions.com",
    "founded": "Not specified for the product; Medtronic was founded in 1949.",
    "headquarters": "Minneapolis, Minnesota (Parent company Medtronic)",
    "pricing_model": "Not explicitly stated, but typical for medical devices: direct sales, potentially lease agreements, and sales of consumables/disposable tools.",
    "core_products": "ILLUMISITE™ fluoroscopic navigation platform; associated biopsy tools including Sensing catheters, Arcpoint™ pulmonary needle, GenCut™ core biopsy system, SuperLock™ nitinol coil fiducial markers; and the LungGPS™ patient management platform.",
    "key_differentiator": "Real-time correction for CT-to-body divergence in dynamic lung environments, continuous guidance for accurate nodule navigation across multiple tool uses, compatibility with digital fluoroscopes, and an integrated suite of diagnostic and patient management tools.",
    "target_markets": "Healthcare providers (pulmonologists, thoracic surgeons, interventional radiologists), hospitals, and medical institutions focused on lung cancer diagnosis and interventional pulmonology.",
    "employee_count": "Not specified for the product, but parent company Medtronic has over 95,000 employees globally.",
    "funding_stage": "Not applicable; product of a large, publicly traded corporation.",
    "subcategory": "Interventional Pulmonology"
  },
  "intentTags": {
    "problemIntents": [
      "How to accurately biopsy lung nodules?",
      "Challenges of lung motion during biopsy",
      "Improving lung cancer diagnosis accuracy",
      "Managing CT-to-body divergence in lung procedures",
      "Detecting hard-to-reach lung lesions"
    ],
    "solutionIntents": [
      "Fluoroscopic navigation system for lung biopsy",
      "Real-time guidance for lung nodule procedures",
      "Integrated lung biopsy platform",
      "Tools for transbronchial access",
      "Software for lung patient management"
    ],
    "evaluationIntents": [
      "ILLUMISITE platform reviews",
      "Accuracy of lung navigation systems",
      "Benefits of real-time CT-to-body divergence correction",
      "Comparison of lung biopsy tools",
      "Clinical evidence for fluoroscopic navigation"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1786549383223
}